Imagion Biosystems Ltd (IBX) - Total Liabilities

Latest as of December 2025: AU$4.21 Million AUD ≈ $2.98 Million USD

Based on the latest financial reports, Imagion Biosystems Ltd (IBX) has total liabilities worth AU$4.21 Million AUD (≈ $2.98 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Imagion Biosystems Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Imagion Biosystems Ltd's total liabilities have evolved over time, based on quarterly financial data. See Imagion Biosystems Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Imagion Biosystems Ltd Competitors by Total Liabilities

The table below lists competitors of Imagion Biosystems Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
SVP GLOBAL TEXTILES LIMITED NSE:SVPGLOB	India	Rs33.27 Billion
PURE ENERGY MINLS F:AHG	Germany	€158.17K
Samfine Creation Holdings Group Limited NASDAQ:SFHG	USA	$120.51 Million
Weststar Industrial Ltd AU:WSI	Australia	AU$27.33 Million
Brilliant Future AB ST:BRILL	Sweden	Skr46.11 Million
GB Group plc LSE:GBG	UK	GBX193.77 Million
Northern Shield Resources Inc. V:NRN	Canada	CA$451.66K
Azevedo & Travassos S.A SA:AZEV3	Brazil	R$1.06 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Imagion Biosystems Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see IBX company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.48	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.95	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	2.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Imagion Biosystems Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Imagion Biosystems Ltd (2014–2025)

The table below shows the annual total liabilities of Imagion Biosystems Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	AU$4.21 Million ≈ $2.98 Million	-17.31%
2024-12-31	AU$5.09 Million ≈ $3.60 Million	-39.26%
2023-12-31	AU$8.37 Million ≈ $5.93 Million	+58.06%
2022-12-31	AU$5.30 Million ≈ $3.75 Million	+554.19%
2021-12-31	AU$809.88K ≈ $573.04K	-32.80%
2020-12-31	AU$1.21 Million ≈ $852.71K	-36.52%
2019-12-31	AU$1.90 Million ≈ $1.34 Million	+44.02%
2018-12-31	AU$1.32 Million ≈ $932.73K	+91.39%
2017-12-31	AU$688.77K ≈ $487.35K	+52.39%
2016-12-31	AU$451.99K ≈ $319.81K	-95.32%
2015-12-31	AU$9.65 Million ≈ $6.83 Million	+123.93%
2014-12-31	AU$4.31 Million ≈ $3.05 Million	--

About Imagion Biosystems Ltd

AU:IBX Australia Diagnostics & Research

Market Cap

$5.55 Million

AU$7.85 Million AUD

Market Cap Rank

#28362 Global

#1516 in Australia

Share Price

AU$0.02

Change (1 day)

+6.67%

52-Week Range

AU$0.01 - AU$0.05

All Time High

AU$8.60